A robot maker that started by automating factories rather than chasing humanoid (人形机器人) headlines just became a public company in Hong Kong. On 9 July 2026, ROKAE (Shandong) Robotics Group (珞石机器人) began trading on the Main Board under code 03752.HK. The listing is a useful window into how China's robotics firms actually finance scale — through exports, component breadth, and patient industrial demand rather than consumer spectacle.
Key takeaways
- ROKAE (珞石机器人) listed on HKEX on 9 July 2026 at stock code 03752.HK, offer price HK$38.00 per share.
- The global offering issued 26,486,600 H shares (including a 3,454,700-share over-allotment), for gross proceeds of about HK$1.006B (≈ US$129M; ≈ RMB 873M).
- Net proceeds are earmarked for R&D, overseas sales, capacity, and strategic investment through 2029; the final amount came in above the pre-listing estimate once the over-allotment option was exercised.
- ROKAE makes industrial robots, flexible collaborative robots (协作机器人), and embodied-intelligence (具身智能) robots, shipping to 40+ countries.
- Despite growing revenue, the company posted net losses of RMB 157M, 192M, and 179M in 2023–2025 — a reminder that robotics IPOs price growth, not profit yet.
The offering, by the filings
The numbers come straight from ROKAE's own post-listing disclosure on HKEX. At HK$38.00 per share, the company issued 26,486,600 H shares including the exercised over-allotment option of 3,454,700 shares. Gross proceeds reached approximately HK$1,006.5M (about RMB 873.2M). A pre-listing report from Securities Times (证券时报) had estimated gross proceeds of HK$875M and net proceeds of HK$811M before over-allotment; the final figure with the option exercised came in higher, as expected.
Cornerstone investors included Beijing Financial Street Capital, All View Focus Fund, Huatai Capital, GF Fund Management, and Yishao Capital. The joint sponsors were CICC and Guotai Junan. The use-of-proceeds plan splits across R&D and product range (about 35%), overseas sales network (about 25%), production capacity (about 22%), strategic investment (about 8%), and working capital (about 10%) — a bland but telling map of where a Chinese robot firm thinks growth lives: product depth, foreign markets, and factories.
Why a robot maker, why Hong Kong
ROKAE is not a humanoid (人形机器人) story. Its core is industrial and collaborative robots — the arms and controllers that weld, assemble, and move goods inside factories. That is a slower, stickier business than bipedal demo reels, and it is exactly the kind of cash-flow-visible manufacturing that Hong Kong investors, with their taste for industrials, tend to underwrite. The embodied-intelligence (具身智能) label appears in the prospectus as a forward bet, but the revenue today is machines on factory floors.
Listing in Hong Kong rather than the mainland gives ROKAE access to international capital and a valuation benchmark against peers in the cluster of Chinese robot names that have listed in the city through 2025–2026. For a company selling to 40-plus countries, a HKEX quote may also serve as a credibility signal for overseas customers and suppliers.
ROKAE is part of a broader cohort. Through 2025 and 2026 a number of Chinese robotics and automation firms listed in Hong Kong rather than on the mainland's STAR Market or ChiNext. The pattern says something about the sector's maturity: the marquee demos may come from humanoid (人形机器人) labs, but the listings — and the cash — are increasingly anchored by firms shipping real machines to real factories today. That is the investor base ROKAE is now answerable to every interim report.
The profit question
The filings are candid about losses. ROKAE recorded net losses of RMB 157M (2023), RMB 192M (2024), and RMB 179M (2025). That profile — growing top line, persistent bottom-line red — is common among hardware-heavy robotics firms scaling capacity and R&D ahead of margin. The IPO math therefore asks investors to underwrite a multi-year path to profit, not a near-term earnings print. The net raise, spread across four years of planned investment, is sized to buy that time.
What readers can do now
- If you follow robotics equities, separate humanoid (人形机器人) hype from industrial-robot fundamentals. ROKAE's listing is a cleaner read on the boring, profitable-eventually side of the sector.
- Treat the loss-making IPO as a bet on capacity, not current cash flow. Check future interim reports for whether revenue growth is outrunning R&D and capacity spend.
- Use HKEX filings as the source of truth. The prospectus and post-listing interim report are public; marketing summaries from brokers are not a substitute.
Honest limitations
Key figures — listing date, stock code, offer price, shares issued, gross and net proceeds, cornerstone investors, sponsors, and the 2023–2025 net-loss amounts — are drawn from ROKAE's HKEX post-listing interim report and interim results announcement (both official exchange filings) and a Securities Times (证券时报) pre-listing report. I have not accessed the full prospectus, so the precise allocation percentages of use-of-proceeds (35/25/22/8/10) come from the stcn summary and are reported as such. The US$ and RMB conversions from HK$ use approximate rates (HK$7.8≈US$1, HK$1≈RMB 0.87) and are labeled approximate. I did not independently verify ROKAE's customer count or country reach beyond the filings' stated "40-plus countries," and I have not compared its margins to listed peers. This is a capital-markets read, not a product or technology review.